[Retrospective evaluation of equine blood cultures sampled between 2022 and 2024]

Marie-Louise Geisler1, Anton Heusinger1, Elisabeth Müller1

  • 1Laboklin GmbH und Co. KG, Bad Kissingen.

Abstract